Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- ‘A great step forward’: The next wave of rheum therapies offers ‘tantalizing’ approaches Rob Volansky
-
- The next generation of rheum agents: Immunomodulation with neonatal Fc receptor targeting? Leonard H. Calabrese, DO
- Obinutuzumab improves odds of complete renal response, cuts flare risk in lupus nephritis Jason Laday
- Medicare fails to ‘keep up with’ Medicaid, private market on infliximab biosimilar uptake Robert Stott
- ACR keynote: AI in medicine ‘could be exciting or it could be terrifying’ Rob Volansky
- Black women with lupus who experience racial discrimination have worse inflammation Erich Martin
- FDA denies Stelara biosimilar application from Alvotech
- FDA expands approval of abatacept for children with psoriatic arthritis Jason Laday
- Financial disclosures in top rheumatology journals often inaccurate Erich Martin
-
- Guselkumab improves biomarkers in TNFi non-responders with psoriatic arthritis Erich Martin
- Little evidence suggests clear superiority of any drug class in rheumatoid arthritis Erich Martin
- New tool uses clinical variables to predict psoriatic arthritis in patients with psoriasis Erich Martin
- One in five immunosuppressed patients lack any response after three COVID vaccine doses Erich Martin
- ‘Pain is the most important symptom’: Helping patients navigate the dangers of OTC NSAIDs Erich Martin
- Patients hospitalized for rotavirus more likely to develop childhood autoimmune disease Erich Martin
- Point-Counterpoint: In-person conferences vs. hybrid options Rob Volansky
- Psychiatric symptom burden in SARDs higher, ‘more wide-ranging’ than previously recorded Erich Martin
-
- Real-world monitoring of rheumatoid arthritis-associated ILD ‘suboptimal’ Rob Volansky
- Stem cell injections improve pain, function in knee osteoarthritis Erich Martin
- Women at significant risk for urinary, genital infections while using SGLT2 inhibitors Rob Volansky